Related Experiment Videos
Effect of surgery on obstructive sleep apnea
T Nishimura1, N Morishima, S Hasegawa
1ENT Department of Fujita Health University Second Hospital, Nagoya, Japan.
Acta Oto-Laryngologica. Supplementum
|January 1, 1996
Summary
Surgical interventions for sleep apnea syndrome significantly improved outcomes in children and adults. Adenotonsillectomy was effective for children, while adults saw varied results with UPPP, MLG, and nasal surgeries.
Area of Science:
- Otolaryngology
- Sleep Medicine
- Surgical Outcomes
Background:
- Sleep apnea syndrome presents with snoring and related symptoms.
- Surgical treatment is a common intervention for sleep apnea syndrome.
- Evaluating surgical efficacy requires objective measures like the Apnea-Hypopnea Index (AHI).
Purpose of the Study:
- To statistically analyze the pre- and post-operative outcomes of patients treated surgically for sleep apnea syndrome.
- To assess the effectiveness of different surgical procedures in children and adults.
Main Methods:
- A retrospective analysis of 149 patients (55 children, 94 adults) treated over three years.
- Children underwent adenotonsillectomy; adults received uvulopalatopharyngoplasty (UPPP), midline laser glossectomy (MLG), and/or nasal surgery.
- Outcomes were measured by changes in the Apnea-Hypopnea Index (AHI), with defined criteria for marked improvement, improvement, slight improvement, and no improvement.
Main Results:
- In children with AHI > 5, 86% showed marked improvement post-adenotonsillectomy.
- In adults, 48% demonstrated marked improvement after UPPP, MLG, and/or nasal surgery.
- Significant improvement rates varied, with 21% of adults showing no improvement.
Conclusions:
- Surgical treatment, particularly adenotonsillectomy, is highly effective for improving sleep apnea syndrome in children.
- Surgical outcomes in adults are more variable, suggesting the need for tailored treatment approaches.
- Further research may explore factors influencing adult surgical success rates in sleep apnea syndrome.